miRNA gene miRNA_log2FC miRNA_pvalue gene_log2FC gene_pvalue interactions correlation_beta correlation_pvalue PMID evidence outcome cancer hsa-miR-145-5p ABCE1 -0.5395243863207 0.275517721230259 0.215315266914843 0.385096739839875 MirTarget -0.10721099105886 2.56784180648568e-06 NA NA NA hsa-miR-145-5p ACVR1B -0.5395243863207 0.275517721230259 0.487426102638866 0.0372822474943607 MirTarget;miRNATAP -0.105422940805648 1.01902804477358e-06 NA NA NA hsa-miR-145-5p ADI1 -0.5395243863207 0.275517721230259 0.00206670168263656 0.993861593482766 MirTarget -0.120067487161347 2.08282813198858e-12 NA NA NA hsa-miR-145-5p ADM2 -0.5395243863207 0.275517721230259 0.176709883800704 0.376640336152169 mirMAP -0.384151076335156 3.76713066484619e-11 NA NA NA hsa-miR-145-5p AIFM1 -0.5395243863207 0.275517721230259 0.141402745646877 0.583261483221174 miRNATAP -0.174994403068684 5.11571157930332e-11 20332243 Artificial overexpression of miR145 by using adenoviral vectors in prostate cancer PC-3 and DU145 cells significantly downregulated BNIP3 together with the upregulation of AIF reduced cell growth and increased cell death prostate cancer hsa-miR-145-5p AKIRIN1 -0.5395243863207 0.275517721230259 0.539535510679253 0.0282764920445964 miRNATAP -0.13429803101473 1.30840537833571e-08 NA NA NA hsa-miR-145-5p AKR1B10 -0.5395243863207 0.275517721230259 -0.0432956693831445 0.910967698583294 miRNAWalker2_validate -0.308244291507663 0.00422623000532109 NA NA NA hsa-miR-145-5p APH1A -0.5395243863207 0.275517721230259 0.3038638892483 0.329703939456281 miRNAWalker2_validate -0.149150638544657 1.20767061860197e-16 NA NA NA hsa-miR-145-5p ARPC5 -0.5395243863207 0.275517721230259 0.143107924865319 0.632333539766005 MirTarget -0.101794256261054 4.61901158001487e-08 NA NA NA hsa-miR-145-5p BNIP3 -0.5395243863207 0.275517721230259 -0.262395163478538 0.300879847545245 miRNAWalker2_validate;miRTarBase -0.233500800665715 5.06052553046421e-11 20332243 Artificial overexpression of miR145 by using adenoviral vectors in prostate cancer PC-3 and DU145 cells significantly downregulated BNIP3 together with the upregulation of AIF reduced cell growth and increased cell death; Analysis of prostate cancer n = 134 and benign prostate n = 83 tissue sample showed significantly decreased miR145 and increased BNIP3 expression in prostate cancer P < 0.001 particularly in those with tumor progression and both molecular changes were associated with unfavorable outcome progression prostate cancer hsa-miR-145-5p C1QL4 -0.5395243863207 0.275517721230259 1.1746117429784 0.00010764011004804 miRNATAP -0.352947414318751 3.56890613437995e-05 NA NA NA hsa-miR-145-5p CD47 -0.5395243863207 0.275517721230259 1.2515151608446 2.27868855017576e-05 miRNATAP -0.137400050061419 3.03639850506568e-05 NA NA NA hsa-miR-145-5p CDR2L -0.5395243863207 0.275517721230259 0.999314267410524 5.35294226719694e-05 MirTarget;miRNATAP -0.113596629938868 0.000542966121214852 NA NA NA hsa-miR-145-5p CHAC2 -0.5395243863207 0.275517721230259 0.223228628482776 0.0798225047789339 MirTarget -0.267047890811 1.25553555766453e-14 NA NA NA hsa-miR-145-5p CLDN9 -0.5395243863207 0.275517721230259 2.65549925559857 1.35151793055789e-19 MirTarget -0.430710076850565 4.42155538046099e-07 NA NA NA hsa-miR-145-5p COMMD5 -0.5395243863207 0.275517721230259 -0.0421291592580371 0.841277799661876 MirTarget -0.123769756870416 4.28964859097668e-11 NA NA NA hsa-miR-145-5p COX16 -0.5395243863207 0.275517721230259 -0.0962811026101145 0.672433627774321 MirTarget -0.111439177252028 7.96242447058312e-07 NA NA NA hsa-miR-145-5p CSTF3 -0.5395243863207 0.275517721230259 -0.00889969102272214 0.965636754529844 MirTarget -0.126542173656708 1.59425532500542e-11 NA NA NA hsa-miR-145-5p DLX6 -0.5395243863207 0.275517721230259 -1.09016536654794 0.000104582802003467 miRNATAP -0.210010729236601 0.00750464987295179 NA NA NA hsa-miR-145-5p DNAJB11 -0.5395243863207 0.275517721230259 0.51565148233342 0.0424512431809738 miRNATAP -0.211049116339941 7.51059353689765e-21 NA NA NA hsa-miR-145-5p DNMT3B -0.5395243863207 0.275517721230259 0.761445118174665 4.439887614372e-06 MirTarget -0.314146758924336 2.83680297593839e-14 24071015;25749421 In univariate analysis the combination of DNMT3B overexpression and miR-145 or miR-143 down-regulation was more powerful in predicting shorter survival P < .05 than use of the biomarkers individually P > .05; DNMT3B might be a potential target of miR-145 and miR-143 in ECs; Furthermore the combined miR-145 or miR-143 and DNMT3B status may have a prognostic impact on ECs;It was found that miR-145 upregulates while DNMT3b downregulates in PC3 cells; Responses of the miR-145 and DNMT3b to irradiation are a negative correlation; We also found that either overexpression of miR-145 or knockdown of DNMT3b sensitized prostate cancer cells to X-ray radiation poor survival;drug resistance endometrial cancer;prostate cancer hsa-miR-145-5p DTD1 -0.5395243863207 0.275517721230259 0.231190139683435 0.26537474498839 miRNAWalker2_validate -0.100149506455237 2.71685695885863e-06 NA NA NA hsa-miR-145-5p E2F3 -0.5395243863207 0.275517721230259 0.509654782474763 0.00503439624753004 miRNATAP -0.202026067472556 3.28431479850552e-18 25762621 miR 145 mediates the antiproliferative and gene regulatory effects of vitamin D3 by directly targeting E2F3 in gastric cancer cells; Furthermore miR-145 expression was lower in tumors compared with matched normal samples and correlated with increased the E2F3 transcription factor protein staining gastric cancer hsa-miR-145-5p EFNA3 -0.5395243863207 0.275517721230259 0.300575362892451 0.0716974751650462 miRNATAP -0.254559290849406 2.37927972865802e-11 NA NA NA hsa-miR-145-5p ELFN2 -0.5395243863207 0.275517721230259 2.04990352843969 4.40208678334906e-12 mirMAP -0.248908086021073 0.00268503741961617 NA NA NA hsa-miR-145-5p ELK4 -0.5395243863207 0.275517721230259 0.0968473981299858 0.422099040377867 miRNATAP -0.124819275508578 6.53954129326428e-08 NA NA NA hsa-miR-145-5p ENC1 -0.5395243863207 0.275517721230259 -0.364138998105254 0.158093266745337 MirTarget -0.146493483957142 0.000341478429205743 NA NA NA hsa-miR-145-5p ESCO2 -0.5395243863207 0.275517721230259 -0.221050893514493 0.212960371708474 MirTarget -0.462138048968643 5.18143995843449e-18 NA NA NA hsa-miR-145-5p F11R -0.5395243863207 0.275517721230259 -0.12846393858057 0.668130991313539 miRNAWalker2_validate -0.175003655280326 2.84565650300966e-10 20818426;26374689 Our data identify JAM-A and fascin as novel targets of miR-145 firmly establishing a role for miR-145 in modulating breast cancer cell motility;MicroRNA screening predicted that microRNA-145 miR-145 would bind to JAM-A; Using patient-derived glioblastoma CSCs we confirmed that JAM-A is suppressed by miR-145 motility; breast cancer;glioblastoma hsa-miR-145-5p FAM110C -0.5395243863207 0.275517721230259 -0.292962530514355 0.184074927119814 MirTarget -0.121839791673166 0.0489164072604947 NA NA NA hsa-miR-145-5p FAM49B -0.5395243863207 0.275517721230259 0.705514524763158 0.00115722383119114 MirTarget -0.249823945832946 3.87052072512419e-19 NA NA NA hsa-miR-145-5p FOXD4 -0.5395243863207 0.275517721230259 -0.188090964980183 0.204507990224729 MirTarget -0.133484998688038 0.001381316553118 NA NA NA hsa-miR-145-5p FOXD4L1 -0.5395243863207 0.275517721230259 -0.0934670042770945 0.53983682713049 MirTarget -0.121410785709047 0.00305782515519928 NA NA NA hsa-miR-145-5p GATC -0.5395243863207 0.275517721230259 0.0269709280020646 0.826169476000788 MirTarget -0.103105828879516 0.00218454714997262 NA NA NA hsa-miR-145-5p GGT7 -0.5395243863207 0.275517721230259 0.481231696742382 0.0266025377557336 MirTarget;miRNATAP -0.105984778057236 0.000587797474070022 NA NA NA hsa-miR-145-5p GMFB -0.5395243863207 0.275517721230259 0.253603397558408 0.282942117122711 miRNAWalker2_validate -0.120811913628986 3.39736019214073e-07 NA NA NA hsa-miR-145-5p GTPBP8 -0.5395243863207 0.275517721230259 0.397355752602739 0.00473297798597804 MirTarget -0.130994670539423 1.96849765384209e-10 NA NA NA hsa-miR-145-5p H2AFX -0.5395243863207 0.275517721230259 0.00243089795796525 0.992125889872964 MirTarget;miRNATAP -0.169250011337871 8.25242109303605e-09 NA NA NA hsa-miR-145-5p HDAC2 -0.5395243863207 0.275517721230259 0.250754952831032 0.381917900336801 miRNAWalker2_validate -0.128094329228912 3.59169770877007e-10 23499894 MiR 145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer; Ectopic expression of miRNA mimics evidenced that miR-145 suppresses HDAC2 expression in HCC cells; In conclusion we suggest that loss or suppression of miR-145 may cause aberrant overexpression of HDAC2 and promote HCC tumorigenesis tumorigenesis liver cancer hsa-miR-145-5p HLTF -0.5395243863207 0.275517721230259 0.356803770209633 0.134158336382827 miRNAWalker2_validate -0.132058294542895 1.3471726325887e-05 25666710 We show that miR-145 targets the DNA damage repair-associated gene Helicase-like transcription factor HLTF which is involved in radio-resistance drug resistance cervical and endocervical cancer hsa-miR-145-5p HN1L -0.5395243863207 0.275517721230259 -0.327928453750742 0.263132060892925 mirMAP -0.123653007926112 5.1623283495294e-09 NA NA NA hsa-miR-145-5p ITGB8 -0.5395243863207 0.275517721230259 0.988671728314465 0.000340058909210288 miRNAWalker2_validate;miRTarBase;MirTarget -0.164296838038098 0.000154326441266007 NA NA NA hsa-miR-145-5p IVNS1ABP -0.5395243863207 0.275517721230259 -0.0537392369927074 0.85527753774761 MirTarget;miRNATAP -0.132251069114239 1.24007584952352e-07 NA NA NA hsa-miR-145-5p KLF5 -0.5395243863207 0.275517721230259 0.314007613572921 0.234026427455351 miRTarBase;miRNATAP -0.11336080393365 0.00706693105451549 NA NA NA hsa-miR-145-5p KRT7 -0.5395243863207 0.275517721230259 1.93835095539445 2.73455372743637e-07 miRNAWalker2_validate -0.372773598102003 5.07754636992227e-06 NA NA NA hsa-miR-145-5p KSR2 -0.5395243863207 0.275517721230259 0.60946281501798 0.000983018141367004 mirMAP -0.212326320173342 2.89588634471192e-05 NA NA NA hsa-miR-145-5p LLPH -0.5395243863207 0.275517721230259 0.130152883736811 0.517749883049055 MirTarget -0.109365173320328 3.20202331217007e-10 NA NA NA hsa-miR-145-5p LRRC8B -0.5395243863207 0.275517721230259 -0.0039987649304587 0.982212848469465 miRNATAP -0.137548358555674 1.85079058039447e-09 NA NA NA hsa-miR-145-5p LYPLA2 -0.5395243863207 0.275517721230259 0.15139187357224 0.564581956605324 miRNAWalker2_validate -0.127866407764731 9.17102184311301e-09 NA NA NA hsa-miR-145-5p MAGOHB -0.5395243863207 0.275517721230259 0.115167578594626 0.48811363657144 MirTarget -0.133965735144503 2.83575028843878e-09 NA NA NA hsa-miR-145-5p MAP2K6 -0.5395243863207 0.275517721230259 -1.19734048917885 3.79707935783786e-09 miRNAWalker2_validate -0.149225425304863 0.00340935708444118 NA NA NA hsa-miR-145-5p MEST -0.5395243863207 0.275517721230259 0.6612769997147 0.0121267813746886 miRNAWalker2_validate;MirTarget;miRNATAP -0.26821063624201 8.01519046662584e-13 NA NA NA hsa-miR-145-5p MGAT4A -0.5395243863207 0.275517721230259 1.19335288762952 1.1611729279008e-07 mirMAP -0.186825861785409 1.4440113944493e-07 NA NA NA hsa-miR-145-5p MMP1 -0.5395243863207 0.275517721230259 0.842110174031317 0.00435850451223239 miRNAWalker2_validate -0.424315184728237 7.96893257108347e-07 NA NA NA hsa-miR-145-5p MMP12 -0.5395243863207 0.275517721230259 -0.00550907640998788 0.98480952997273 miRNAWalker2_validate -0.479912278816147 1.14727534128625e-08 NA NA NA hsa-miR-145-5p MUC1 -0.5395243863207 0.275517721230259 0.399501991648949 0.266525630346514 miRNAWalker2_validate;miRTarBase -0.233334073885385 0.000158148572697253 24157791 MiR 145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1; MiR-145 is found to negatively regulate P70S6K1 and MUC1 protein levels by directly targeting their 3'UTRs; Importantly the overexpression of p70S6K1 and MUC1 can restore the cell colony formation and invasion abilities that are reduced by miR-145 respectively; Our study suggests that miR-145 modulates ovarian cancer growth and invasion by suppressing p70S6K1 and MUC1 functioning as a tumor suppressor ovarian cancer hsa-miR-145-5p MYO6 -0.5395243863207 0.275517721230259 -0.0334725923511598 0.899090795273878 miRNAWalker2_validate;miRTarBase;MirTarget;miRNATAP -0.132783294843231 6.00402557562689e-06 20353999 A computational search indicated the 3'-untranslated region UTR of the mRNA for myosin VI MYO6 as a potential target for both miR-143 and miR-145 the expression of which was reduced in the tumor tissues; In luciferase reporter analysis we find a significant negative regulatory effect on the MYO6 3'UTR by both miR-143 and miR-145; Mutation of the potential binding sites for miR-143 and miR-145 in the MYO6 3'UTR resulted in a loss of responsiveness to the corresponding miRNA; Our data indicate that miR-143 and miR-145 are involved in the regulation of MYO6 expression and possibly in the development of prostate cancer prostate cancer hsa-miR-145-5p NAA15 -0.5395243863207 0.275517721230259 0.139957404068467 0.533354605915378 miRNATAP -0.112573260679979 6.26932709110513e-08 NA NA NA hsa-miR-145-5p NAA50 -0.5395243863207 0.275517721230259 0.333633536654097 0.227949237682664 MirTarget;miRNATAP -0.163388446896211 8.46777766061892e-16 NA NA NA hsa-miR-145-5p NDUFA4 -0.5395243863207 0.275517721230259 0.0966575661677629 0.742989975089558 miRNAWalker2_validate -0.111993873120167 3.47575613649856e-06 NA NA NA hsa-miR-145-5p NIPSNAP1 -0.5395243863207 0.275517721230259 0.380455196336326 0.140970670421739 miRNAWalker2_validate -0.142958773845128 9.84131337125403e-10 NA NA NA hsa-miR-145-5p NRAS -0.5395243863207 0.275517721230259 0.45874364005328 0.0509322894896378 miRNAWalker2_validate;MirTarget;miRNATAP -0.175244257734617 6.83000988114599e-12 26973415 miR-145 expression was significantly downregulated in colon cancer tissues with its expression in normal colonic tissues being 4-5-fold higher two sample t test P < 0.05 whereas N-ras expression showed the opposite trend colon cancer hsa-miR-145-5p NRCAM -0.5395243863207 0.275517721230259 0.0959760602956168 0.7238227175875 MirTarget -0.155356534193088 0.0196878904633237 NA NA NA hsa-miR-145-5p NSUN4 -0.5395243863207 0.275517721230259 0.127718125218756 0.518433975455802 MirTarget -0.106662677154329 3.45030032046317e-13 NA NA NA hsa-miR-145-5p NUAK2 -0.5395243863207 0.275517721230259 1.06069099938813 3.99698531818286e-07 MirTarget -0.232359440456966 9.48433151186128e-10 NA NA NA hsa-miR-145-5p NUDT1 -0.5395243863207 0.275517721230259 0.172606233930091 0.333441438250458 miRTarBase -0.128767673323414 2.20463728007414e-05 21289483 MiR 145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1; The mRNA expressions of EGFR and NUDT1 were significantly downregulated after miR-145 transfection in human lung adenocarcinoma cells; Our results demonstrated miR-145 in the negative regulation of EGFR and NUDT1 expressions at both mRNA and protein levels; Upregulation of miR-145 appeared to be an important gene regulation mechanism for the proliferation of lung adenocarcinoma cells and it correlated strongly with the downregulation of EGFR and NUDT1; Our findings provided new insight into the complex regulating pathway comprising of miR-145 EGFR NUDT1 and other unknown factors which function in cell proliferation but not in apoptosis lung cancer hsa-miR-145-5p ONECUT2 -0.5395243863207 0.275517721230259 0.7338602984654 0.00177087798212235 mirMAP;miRNATAP -0.333581530382109 5.65978115282115e-07 NA NA NA hsa-miR-145-5p PIGF -0.5395243863207 0.275517721230259 -0.00917768874276526 0.953057701825987 miRNAWalker2_validate;MirTarget -0.115227830760442 7.54768136848484e-13 NA NA NA hsa-miR-145-5p PLAGL2 -0.5395243863207 0.275517721230259 0.635231130792899 0.0067304077373277 MirTarget;miRNATAP -0.147123920652321 1.43230608088157e-08 NA NA NA hsa-miR-145-5p PTP4A2 -0.5395243863207 0.275517721230259 0.378056417797843 0.154193967944796 miRNAWalker2_validate;MirTarget;miRNATAP -0.116474153180554 2.71112253363447e-10 NA NA NA hsa-miR-145-5p RAB11FIP4 -0.5395243863207 0.275517721230259 0.746766343577468 0.00175545412246216 MirTarget -0.324184208682902 8.46840969804318e-17 NA NA NA hsa-miR-145-5p RTKN -0.5395243863207 0.275517721230259 0.150939679254789 0.497351727092801 miRNAWalker2_validate;MirTarget;miRNATAP -0.156977236571469 2.14312380352194e-12 19360360 miR 145 inhibits breast cancer cell growth through RTKN; Subsequently RTKN is identified as a potential miR-145 target by bioinformatics; Using reporter constructs we show that the RTKN 3' untranslated region 3'UTR carries the directly binding site of miR-145; Additionally overexpression of miR-145 in MCF-7 reduces RTKN protein expression as well as mRNA level; Taken together we propose that loss of miR-145 may provide a selective growth advantage for MCF-7 by targeting RTKN breast cancer hsa-miR-145-5p SAMD12 -0.5395243863207 0.275517721230259 0.702302926840855 0.00255514153811606 miRNATAP -0.109066758471742 0.0247761135186046 NA NA NA hsa-miR-145-5p SCAMP3 -0.5395243863207 0.275517721230259 0.0610729880326728 0.806395108157023 MirTarget;miRNATAP -0.154083753121021 1.91611254036639e-15 NA NA NA hsa-miR-145-5p SEL1L3 -0.5395243863207 0.275517721230259 -0.728401378007842 0.00406547979098702 miRNATAP -0.162344208301523 5.3674357382031e-06 NA NA NA hsa-miR-145-5p SHISA9 -0.5395243863207 0.275517721230259 0.420652557824043 0.176234444800526 MirTarget -0.433892733279421 4.95864872830676e-07 NA NA NA hsa-miR-145-5p SLC19A1 -0.5395243863207 0.275517721230259 -0.201978514990779 0.25408083727204 mirMAP -0.16031095456702 9.21699516202072e-09 NA NA NA hsa-miR-145-5p SORT1 -0.5395243863207 0.275517721230259 -0.0554343201101082 0.844925384835299 mirMAP -0.108804299708553 2.5376129644604e-06 NA NA NA hsa-miR-145-5p SPATS2 -0.5395243863207 0.275517721230259 -0.535606611503809 0.0137189683313266 MirTarget -0.113055320776853 1.10814128218404e-06 NA NA NA hsa-miR-145-5p STAT1 -0.5395243863207 0.275517721230259 1.05726795031508 0.000691614783476888 miRNAWalker2_validate;miRTarBase -0.21591570231748 4.53372547599817e-09 20098684 MicroRNA 145 targets YES and STAT1 in colon cancer cells; Both YES and STAT1 were verified as direct miR-145 targets colon cancer hsa-miR-145-5p SYAP1 -0.5395243863207 0.275517721230259 -0.219607365776543 0.355689718602223 mirMAP -0.136778793081532 1.75340331689314e-11 NA NA NA hsa-miR-145-5p TARS2 -0.5395243863207 0.275517721230259 0.310592082238647 0.123576564665526 MirTarget -0.203651198019413 8.33792631502356e-24 NA NA NA hsa-miR-145-5p TFCP2L1 -0.5395243863207 0.275517721230259 -0.11100579446354 0.652895489247317 mirMAP -0.321388288933044 4.67140802288455e-07 NA NA NA hsa-miR-145-5p TMEM139 -0.5395243863207 0.275517721230259 0.488185620993369 0.0293131370310094 MirTarget -0.190993248298973 5.58413493932514e-05 NA NA NA hsa-miR-145-5p TPM3 -0.5395243863207 0.275517721230259 0.0378282185372711 0.90657556776086 miRNAWalker2_validate -0.171835294994172 3.61071812732848e-21 NA NA NA hsa-miR-145-5p TXNDC9 -0.5395243863207 0.275517721230259 0.451298437893302 0.0202155561298868 MirTarget -0.146490628229316 3.34153374081969e-10 NA NA NA hsa-miR-145-5p UNC13A -0.5395243863207 0.275517721230259 1.22860622476545 7.60294725807242e-08 mirMAP -0.178413852795447 0.00559456449710522 NA NA NA hsa-miR-145-5p VAX1 -0.5395243863207 0.275517721230259 -0.598910634613528 0.107121307596039 mirMAP -0.20611616569494 0.0216122693279138 NA NA NA hsa-miR-145-5p VEGFA -0.5395243863207 0.275517721230259 0.32167827094894 0.276880944299993 miRNAWalker2_validate;miRTarBase -0.164162126313281 1.21123406126454e-06 24781864;24966896;22472569 Overexpression of miR-145 in thyroid cancer cell lines resulted in: decreased cell proliferation migration invasion VEGF secretion and E-cadherin expression; In vivo miR-145 overexpression decreased tumor growth and metastasis in a xenograft mouse model and VEGF secretion;The ectopic expression of miR-1 and miR-145 in NOZ cells significantly inhibited cell viability and colony formation P<0.01 and reduced gene expression of VEGF-A and AXL;Furthermore the results showed that vascular endothelial growth factor VEGF expression was down-regulated in osteosarcoma cells after miR-145 transfection; On the basis of these results we performed the luciferase assay and verified that miR-145 could down-regulate VEGF at the translational level by partially binding to VEGF 3' untranslated region 3'UTR; One of the mechanisms is the down-regulation of VEGF expression by miR-145 by binding to the 3'UTR of VEGF mRNA specifically metastasis;; thyroid cancer;bladder cancer;sarcoma hsa-miR-145-5p ZBTB33 -0.5395243863207 0.275517721230259 0.284664039074368 0.170681528396922 MirTarget -0.101122216477814 1.97308340821643e-07 NA NA NA hsa-miR-145-5p ZDHHC9 -0.5395243863207 0.275517721230259 -0.316895965111851 0.176187359122359 MirTarget;miRNATAP -0.105655571980029 1.27715485244695e-05 NA NA NA hsa-miR-145-5p ZNF593 -0.5395243863207 0.275517721230259 -0.0559066791402101 0.787380550494405 MirTarget -0.117445961035535 1.9792489196246e-05 NA NA NA